Michelson Prizes laureates are distinguished scientists that have been recognized for their research and work to chart the future of human health.
Scott B. Biering, Ph.D.
Michelson Philanthropies & Science Prize for Immunology | 2022 Finalist Winner
To determine how anti-NS1 antibodies protect against flavivirus infection and how NS1 triggers pathogenesis, Dr. Scott Biering and his team solved a crystal structure of a protective and cross-reactive monoclonal antibody 2B7 in complex with dengue virus NS1.
Postdoctoral Scholar, University of California, Berkeley
Michael Birnbaum, Ph.D., Assistant Professor
Michelson Prizes: Next Generation Grants | 2020 Winner
Dr. Michael Birnbaum studies “elite controllers”—those rare individuals with HIV who can go for long periods without antiretroviral therapy—to identify optimal vaccine targets for stopping the virus.
Assistant Professor, Department of Biological Engineering, MIT
Danika Hill, Ph.D.
Michelson Prizes: Next Generation Grants | 2020 Winner
Dr. Danika Hill is using strep A bacteria to identify the specific antigens that trigger the immunity protections of our bodily fluids.
Research Fellow, Department of Immunology and Pathology, Monash University, Melbourne, Australia
Avinash Das Sahu, Ph.D.
Michelson Prizes: Next Generation Grants | 2019 Winner
Dr. Sahu is building novel artificial intelligence, deep-learning frameworks to devise new therapeutic strategies for cancer immunotherapy, with potential applications to human immunology.
Postdoctoral Fellow, Department of Data Sciences, Dana-Farber Cancer Institute | Sahu Laboratory , The University of New Mexico Comprehensive Cancer Center
Kamal Mandal, Ph.D.
Michelson Prizes: Next Generation Grants | 2019 Winner
Dr. Mandal is developing new technologies that identify the shape of proteins that could provide new targets for cancer immunotherapy, with potential applications to other diseases.
Postdoctoral Scholar, Laboratory Medicine, School of Medicine, University of California, San Francisco
Murad Mamedov, Ph.D.
Michelson Prizes: Next Generation Grants | 2019 Winner
Dr. Mamedov is using gene-editing technologies to create a new platform for understanding an important set of immune cells that may provide the keys to the diagnosis, prevention, and treatment of infectious and noncommunicable diseases such as cancer.
Postdoctoral Scholar, Microbiology and Immunology, School of Medicine, University of California, San Francisco
